As a Research Associate at the National Taiwan University, I specialize in perinatal pharmacoepidemiology, with a focus on maternal mental health disorders.
Considering the exclusion of pregnant women from clinical trials, I recognize the crucial role that real-world data plays in addressing clinical queries and ensuring drug safety for pregnant women. The research conducted by the PharmaSafe research group has had a major influence on my work. Indeed, one of my studies, significantly inspired by their work, was recognized as the spotlight poster winner in the "Medication in Pregnancy and Lactation" section at the ICPE 2022.
I am delighted to have the chance to collaborate with the PharmaSafe group. During my visit, I will delve into the safety of paternal drug exposure and its impact on congenital malformations. I will also facilitate an international study between Norway and Taiwan. I am deeply honored and grateful to join iAPOGEE, and am eagerly looking forward to my collaboration with the PharmaSafe research group.